Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

BlackBerry

Virgin Galactic

Meme stocks are back in the spotlight to begin 2023 (along with crypto) as investors seem to be shaking off the doldrums of the past year and wading back into equities. Several of the most popular meme stocks that took the market by storm in 2021 are up big this month, helping to fuel speculation that a new bull market is emerging and causing some hand wringing on Wall Street among short sellers.

3 Sorry Meme Stocks to Sell in February Before It's Too Late

CarParts.com, Inc.

Ring Energy

Investing in penny stocks can be a great way to get multi-bagger returns on a small investment. But it can also be incredibly risky, especially in the current market environment, as penny stocks are notoriously volatile.

3 Penny Stocks That Will Be Big Winners in 2023

Tesla

These two growth stocks could deliver stellar returns for shareholders over the balance of the decade.

Got $1,000? 2 Heavily Discounted Nasdaq Stocks to Buy and Hold Forever

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Investors should get deep into companies' income statements and balance sheets; focus primarily on last 6-12 months of performance. Tiby Erdely, who came to cannabis from Goldman Sachs and co-founded KEY Investment Partners, talks about why consolidation is coming.

Depressed Valuations, Consolidation Coming (Transcript)

Borr Drilling Ltd

Solid Power

I must admit at the onset that I am not a big fan of investing in penny stocks. To a large extent, penny stocks are speculative and therefore risky.

3 Penny Stocks to Buy Now OR You'll Be Kicking Yourself Later

How should cannabis investors ride the wave of depressed valuations? Tiby Erdely, who came to cannabis from Goldman Sachs and co-founded KEY Investment Partners, talks about why consolidation is coming.

Depressed Valuations,  Consolidation Coming

Canadian Marijuana Stocks To Buy And Watch 2023? The post 2 Marijuana Stocks To Buy Under $5 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Buy Under $5

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

AXS Cannabis ETF

Village Farms International

The Valens Co

Roundhill Cannabis ETF

AdvisorShares Pure Cannabis ETF 

The most consistent progress in cannabis is coming from states continuing to roll out legalization programs. For cannabis companies wanting to make a profit in these legal markets, there is both opportunity and a need to navigate growing pains.

Markets Don't Move In Straight Lines

Cannabis may not be legalized in the U.S. in the near future. Tilray Brands, Inc. is more than a cannabis legalization play since it is growing its beer and spirits business.

Tilray Brands: More Than A Cannabis Stock

Cannabis investors shouldn't assume the stock has bottomed out.

1 Thing Tilray Investors Need to Brace for This Year

New Hazy IPA Adds Depth to Year-Round Lineup as Alpine Expands Distribution into Florida New Hazy IPA Adds Depth to Year-Round Lineup as Alpine Expands Distribution into Florida

Alpine Beer Launches INFINITE HAZE Hazy IPA

Aurora Cannabis

Cronos Group

I wrote a piece last October asking the simple question: whatever happened to the cannabis stock bubble? Biden's election was billed as a massive boost for the cannabis industry.

Why are cannabis stocks rising? Sector bounces following ugly 2022

Are These Best Canadian Marijuana Stocks To Buy In 2023? The post 3 Marijuana Stocks To Watch During The 2nd Week Of 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch During The 2nd Week Of 2023

Celebrating the Launch of Two New Signature Collections: Solei ‘Slims' and CBN Softgels Now Available Across Canada Celebrating the Launch of Two New Signature Collections: Solei ‘Slims' and CBN Softgels Now Available Across Canada

Solei Cannabis Brand Introduces New Approach to Wellness with New Product Lineup and Brand Refresh

Aurora Cannabis won't be profitable this year, but one other marijuana stock might be.

Why Aurora Cannabis and Other Marijuana Stocks Just Popped

SweetWater Brings Back Georgia Brown Ale and Exodus Porter Beers for the Winter

SweetWater Brewing Company Celebrates 26 Years of Brewing with Throwback Beers, Jam Bands

Tilray missed fiscal Q2 2023 EPS and sales expectations, but analysts are looking for smaller losses going forward. The post Is TLRY Stock A Buy After A New Acquisition and State Level Legalizations?

Is TLRY Stock A Buy After A New Acquisition and State Level Legalizations?

Tilray Inc (NASDAQ:TLRY) remained on the 'Buy' list at Canaccord Genuity (TSX:CF, LSE:CF) but analysts cut their price target following a weaker-than-anticipated second quarter print. In a note the broker said the results, combined with the recent softening of US federal catalysts following the conclusion of the congressional “lame-duck” session, which "ultimately did not advance any cannabis reforms" had prompted it to reduce its target to US$5 from US$7.

Tilray Brands remains a Buy at Canaccord despite reduced price target

Shares of Tilray Inc (NASDAQ: TLRY) ended about 7.0% down on Monday after the cannabis company reported a loss for its second financial quarter. Tilray CEO reacts to the earnings report Still, CEO Irwin Simon is satisfied with the quarterly performance.

Tilray CEO is ‘happy' despite Q2 loss

Tilray reported earnings which are likely to pace Canadian peers. The company delivered its 15th consecutive quarter of positive adjusted EBITDA and even generated positive free cash flow.

Tilray Reports Earnings Amidst Progress Toward U.S. Cannabis Legalization

Tilray Brands Inc. CEO Irwin Simon is keeping an eye out for more acquisitions on both sides of the Canadian border as the company looks past its second-quarter loss toward growth potential in the alcohol business in the U.S. and the adult use cannabis in the Great White North.

Tilray's alcohol business grows on acquisitions as cannabis faces price compression

Tilray Brands Inc. saw its shares fall after it swung into the red in the second quarter and reported revenue that missed market expectations.

Tilray Brands' shares fall as it swings into the red and revenue misses forecast

While Tilray has maintained its leading market share in the recreational cannabis market in Canada and the medical cannabis market in Europe, its Q2 earnings, which included a loss per share of -$0.11 and an adjusted loss per share of -$0.06, have left investors questioning the company's future growth prospects.

Tilray Q2 Earnings Leave Investors Wanting More

Tilray Brands, Inc. (NASDAQ:TLRY ) Q2 2023 Results Conference Call January 9, 2023 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - Chairman and Chief Executive Officer Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer and Head, International Blair MacNeil - President, Tilray Canada Ty Gilmore - President, U.S. Beer Business Conference Call Participants Victor Ma - Cowen & Company Nadine Sarwat - Bernstein Andrew Carter - Stifel Aaron Grey - Alliance Global Partners Owen Bennett - Jefferies John Zamparo - CIBC Michael Lavery - Piper Sandler Pablo Zuanic - Cantor Fitzgerald Matt Bottomley - Canaccord Frederico Gomes - ATB Capital Operator Greetings. Welcome to Tilray's Second Quarter 2023 Earnings Call.

Tilray Brands, Inc. (TLRY) Q2 2023 Earnings Call Transcript

Investors will likely need to see real progress toward legalization in the U.S. for the stock to get a meaningful catalyst.

Here's Why Tilray Stock Sank Monday

News for Tilray Brands Stock (TLRY)